361 related articles for article (PubMed ID: 11985366)
1. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
[TBL] [Abstract][Full Text] [Related]
2. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
Abbar M; Courtet P; Castelnau D
Encephale; 1996; 22(1):53-63. PubMed ID: 8681876
[TBL] [Abstract][Full Text] [Related]
3. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
[TBL] [Abstract][Full Text] [Related]
4. Clozapine for drug-induced psychosis in Parkinson's disease.
Brown TM
N Engl J Med; 1999 Aug; 341(6):456. PubMed ID: 10438274
[No Abstract] [Full Text] [Related]
5. Clozapine prevents recurrence of psychosis in Parkinson's disease.
Factor SA; Brown D
Mov Disord; 1992; 7(2):125-31. PubMed ID: 1350059
[TBL] [Abstract][Full Text] [Related]
6. Clozapine treatment of psychosis in Parkinson's disease: a report of five consecutive cases.
Wolk SI; Douglas CJ
J Clin Psychiatry; 1992 Oct; 53(10):373-6. PubMed ID: 1358876
[TBL] [Abstract][Full Text] [Related]
7. Clozapine-induced agranulocytosis and thrombopenia in a patient with dopaminergic psychosis.
Rudolf J; Grond M; Neveling M; Heiss WD
J Neural Transm (Vienna); 1997; 104(11-12):1305-11. PubMed ID: 9503276
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment.
Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092
[TBL] [Abstract][Full Text] [Related]
9. [Clozapine in the treatment of mental manifestations of Parkinson disease].
Diederich N; Keipes M; Graas M; Metz H
Rev Neurol (Paris); 1995 Apr; 151(4):251-7. PubMed ID: 7481376
[TBL] [Abstract][Full Text] [Related]
10. Clozapine for the treatment of psychosis in Parkinson's disease: a review.
Auzou P; Ozsancak C; Hannequin D; Moore N; Augustin P
Acta Neurol Scand; 1996 Nov; 94(5):329-36. PubMed ID: 8947285
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of clozapine in the treatment of movement disorders.
Factor SA; Friedman JH
Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065
[TBL] [Abstract][Full Text] [Related]
12. Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.
Rich SS; Friedman JH; Ott BR
J Clin Psychiatry; 1995 Dec; 56(12):556-9. PubMed ID: 8530331
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
Friedman JH; Factor SA
Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
[TBL] [Abstract][Full Text] [Related]
14. Managing psychosis in patients with Parkinson's disease.
Cummings JL
N Engl J Med; 1999 Mar; 340(10):801-3. PubMed ID: 10072418
[No Abstract] [Full Text] [Related]
15. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
Schindehütte J; Trenkwalder C
Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
[TBL] [Abstract][Full Text] [Related]
16. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease.
Parkinson Study Group
N Engl J Med; 1999 Mar; 340(10):757-63. PubMed ID: 10072410
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus among parkinsonian patients treated chronically with clozapine.
Fernandez HH; Friedman JH; Lansang MC; Factor SA; Molho ES; Coskun DJ
Parkinsonism Relat Disord; 2004 Oct; 10(7):439-41. PubMed ID: 15465403
[TBL] [Abstract][Full Text] [Related]
18. [Dopaminomimetic psychosis in Parkinson's disease: first symptom of early dementia?].
Catalan-Alonso MJ; Del Val J
Rev Neurol; 2001 Jun 1-15; 32(11):1085-7. PubMed ID: 11562835
[TBL] [Abstract][Full Text] [Related]
19. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
Greene P; Cote L; Fahn S
Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
[No Abstract] [Full Text] [Related]
20. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
Storch A; Trenkwalder C; Oehlwein C; Winkelmann J; Polzer U; Hundemer HP; Schwarz J
Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
